Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

80.04 +0.14 (+0.18%)
Streaming Delayed Price Updated: 10:09 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
From Aligos Therapeutics
Via GlobeNewswire
News headline image
NYSE:HAE stands out as a growth opportunity that won't break the bank. ↗
Investors should take note ofHAEMONETICS CORP/MASS (NYSE:HAE), a growth stock that remains attractively priced. 
Via Chartmill
News headline image
What Analysts Are Saying About Haemonetics Stock ↗
 
Via Benzinga
News headline image
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced. ↗
Looking for growth without the hefty price tag? Consider NYSE:HAE. 
Via Chartmill
News headline image
Analyst Expectations For Haemonetics's Future ↗
 
Via Benzinga
News headline image
NYSE:HAE stands out as a growth opportunity that won't break the bank. ↗
NYSE:HAE is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
Looking for growth without the hefty price tag? Consider NYSE:HAE. ↗
HAEMONETICS CORP/MASS (NYSE:HAE) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
NYSE:HAE, a growth stock which is not overvalued. ↗
Despite its growth, HAEMONETICS CORP/MASS (NYSE:HAE) remains within the realm of affordability. 
Via Chartmill
News headline image
Top 3 Health Care Stocks That Are Set To Fly This Quarter ↗
 
Via Benzinga
News headline image
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced. ↗
Investors seeking growth at a reasonable cost should explore HAEMONETICS CORP/MASS (NYSE:HAE). 
Via Chartmill
News headline image
Sotera Health Appoints Christopher Simon to the Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
News headline image
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst ↗
Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix analysis. Price target set at $112. 
Via Benzinga
News headline image
This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗
 
Via Benzinga
News headline image
4 Analysts Assess Haemonetics: What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 8, 2024 ↗
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
News headline image
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing? ↗
Why the quality investor may take a look at HAEMONETICS CORP/MASS (NYSE:HAE). 
Via Chartmill
News headline image
These 3 Companies Boast Bright Outlooks ↗
Favorable earnings estimate revisions are key for a stock to move higher. Let’s examine a few highly ranked stocks, including Stride, Interactive Brokers, and Haemonetics. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 ↗
HAE stock results show that Haemonetics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. ↗
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering. 
Via Chartmill
News headline image
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗
Intuitive Surgical stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an increase from 74 to 85. 
Via Investor's Business Daily
News headline image
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise ↗
Intuitive Surgical stock got an IBD rating upgrade Monday. It edged up 0.37% to 274.16, its second day in a row of rising share price. 
Via Investor's Business Daily
News headline image
Exploring NYSE:HAE's quality characteristics. ↗
Should you consider HAEMONETICS CORP/MASS (NYSE:HAE) for quality investing? 
Via Chartmill
News headline image
Should you consider NYSE:HAE for quality investing? ↗
HAEMONETICS CORP/MASS (NYSE:HAE) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
News headline image
4 Analysts Have This to Say About Haemonetics ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Intuitive Surgical Stock Nearly Doubles; Gets Rating Upgrade ↗
Intuitive Surgical stock dipped to an intraday low 180.07 in October last year as the bear market ended, then shot up to 358.07 on July 19. 
Via Investor's Business Daily
News headline image
Haemonetics Earnings Preview ↗
 
Via Benzinga
Haemonetics Corp. (NYSE: HAE) Making Surprising Moves in Monday Session
Via Investor Brand Network
News headline image
Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.